S6937 (2025-26 session)
NY State bill
Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.
- Title
- Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
- Type
- New York State Senate bill
- Session
- 2025-26 session
- Status
- In Senate Committee
- Latest action date
- 2026-01-07
- In committee
- Insurance
- Introduced
- 2025-03-27
- Same as
- A7920
- Law section
- Insurance Law
Sponsors
- Andrew J. Lanza State Senator, District 24
Heard in committee
- Insurance NY State Senate committee